Journal article
Hemolytic Anemia in Patients Receiving Sulfasalazine
Abstract
Hemolytic anemia is a well-recognized complication of sulfasalazine treatment. 17 of 40 (43%) patients with inflammatory bowel disease receiving sulfasalazine had evidence of hemolysis as detected by starch gel electrophoresis. Only 47% (8) of patients with hemolysis had Heinz body formation. The hemoglobin was significantly reduced in patients with hemolysis and 53% had a reticulocyte count of greater than 5%. A significant correlation was …
Authors
Goodacre RL; Ali MAM; Vanderlinden B; Hamilton JD; Castelli M; Seaton T
Journal
Digestion, Vol. 17, No. 6, pp. 503–508
Publisher
Karger Publishers
Publication Date
1978
DOI
10.1159/000198156
ISSN
0012-2823